Clinical Trial Update: A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating nerandomilast in children and adolescents with fibrosing interstitial lung disease to assess tolerability, pharmacokinetics, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibrosing Interstitial Lung Disease

Drugs mentioned

• Nerandomilast

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Fibrosing Interstitial Lung Disease | Phase 3 | Status: NOT_YET_RECRUITING